title: Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine.
abstract: Induced pluripotent stem cells (iPSCs) can be generated from adult somatic tissues by the forced expression of a few defined transcription factors, including Oct4, Sox2, Klf4, and c-Myc. iPSC technology holds tremendous promises for therapeutic cardiovascular regeneration because of the cells' unlimited capacity for proliferation and differentiation into all cell lineages. The iPSCs can be generated from somatic cells of patients with a genetic basis for their disease so as to understand the pathobiology of the disorder. This disease modeling can be adapted to high-throughput screens to discover new therapeutic molecules. Finally, the iPSC technology may enable personalized cell therapies, while avoiding the ethical concerns surrounding human embryonic stem cells. Intensive efforts are underway to develop reliable methods to guide stem cell differentiation into cardiovascular lineages in the treatment of peripheral artery disease and heart diseases. Studies of disease pathogenesis and drug discovery using iPSC technology shall advance the discovery of novel treatments for cardiovascular diseases.
authors.affiliation: Houston Methodist Hospital Research Institute, Houston Methodist Hospital, Houston, Texas.
authors.forename: Wing Tak
authors.initials: WT
authors.lastname: Wong
authors.forename: Nazish
authors.initials: N
authors.lastname: Sayed
authors.forename: John P
authors.initials: JP
authors.lastname: Cooke
mesh_terms: D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000637:transplantation*; D000090062:Kruppel-Like Factor 4; D058729:Peripheral Arterial Disease / Q000628:therapy*; D044968:Regenerative Medicine / Q000379:methods*; D033581:Stem Cell Transplantation / Q000379:methods*
keywords: cardiovascular regeneration; disease modeling; induced pluripotent stem cells